Is Cash Flow Masking Severe Revenue Leakage? 3 Questions Healthcare CEOs Should Ask About Revenue Cycle Management
Hemant Apte, Chief Executive OfficerAugust 24, 2026
Many hospitals are in a good news-bad news position with revenue cycle management, and they might not even know it.
The good news, is that cash flows improved in 2025 [1]. At the same time, leakage has increased severely—a 25% jump and $48.4 billion in revenue that’s gone uncollected. The most important insight in all of this is that even with increases in cash flow, there was no translation to net revenue improvement.
For healthcare revenue cycle management leaders, this highlights the need to address the two potential silos—leadership needs ongoing understanding and monitoring of the net impact of both cash flows and healthcare revenue leakage. Bridging this gap should start with a few, key questions.
How exposed are we to payer-driven revenue risk?
This question is valuable because not all payers carry the same impact on cash flows or leakage. Understanding the net impact of commercial payers versus Medicare or Medicare Advantage can help paint a clearer picture of true impact and minimize the effects of hidden leakage.
Is patient responsibility growth outpacing what we can actually collect?
Patient responsibility is increasing just as those same patients aren’t able to pay as much – patient responsibility rose to 7.3% in 2025 from 6.8% the previous year. At the same time, patient yield fell from 45.1% to 42.4%. This shift represents leakage that can easily be hidden by positive cash flow trends without a deeper look.
Does our RCM services strategy match the scale of this exposure?
Most healthcare revenue cycle management teams are already overstretched. An additional task of reframing tracking, reporting, and responding to leakage issues could be too much to take on right now. Leadership should evaluate its current vendor mix and new potential vendors for opportunities to fill gaps with experienced insight.
The benefit of answering the vendor question as soon as possible is that the right choice can reverberate into longer-term insulation against industry shifts while also supporting deeper education across the organization. To learn where 3Gen Consulting can fit into your RCM services plans, start here.
[1] L. Gale, "Cash Flow Improves Despite $48.4 Billion in Revenue Leakage in 2025," Arrowfly LLC, 27 April 2026. Available: https://www.healthleadersmedia.com/revenue-cycle/cash-flow-improves-despite-484-billion-revenue-leakage-2025.
Hemant Apte, Chief Executive Officer
Hemant Apte is the Founder and CEO of 3Gen Consulting, a leading healthcare revenue cycle management and technology company serving providers, ACOs, and health plans across the U.S. Since founding 3Gen in 2006, Hemant has guided the company’s evolution from a boutique consulting firm into a data-driven organization at the forefront of AI-powered RCM innovation. With decades of experience in U.S. healthcare operations, Hemant continues to provide thought leadership to clients navigating financial, compliance, and technology challenges in an increasingly value-based care environment.
Is Cash Flow Masking a Bigger Revenue Leakage Problem?
Talk to 3Gen about where your RCM strategy may have blind spots.
Connect with our experts to:
- Identify payer-driven revenue gaps
- Assess patient yield trajectory
- Match RCM partner to exposure scale
Explore our strategic insights & resources
View All ResourcesView All Resources
FAQs
The FAQ section simplifies key information about 3Gen Consulting’s services, helping partners navigate our offerings, methodologies, and value.
Talk to an ExpertTalk to an Expert
Healthcare revenue leakage refers to net revenue lost to final claim denials and uncollected patient balances – a measure of what was never collected, not simply what was slow to collect. A March 2026 analysis found that even as cash flow efficiencies improved at over 2,300 hospitals in 2025, net revenue leakage still increased 25% to $48.4 billion – demonstrating that positive cash flow trends can mask significant underlying revenue losses.
Medicare Advantage plans had initial and final denial rates more than double those of traditional Medicare in 2025, while commercial denials created disproportionate revenue leakage because commercial reimbursement rates are higher. Understanding the net impact of each payer category – not just overall denial rates – is essential for healthcare revenue cycle management leaders trying to isolate true leakage exposure.
Patient responsibility as a share of net revenue rose from 6.8% in 2024 to 7.3% in 2025, while the rate at which insured patients actually paid what they owed fell from 45.1% to 42.4% over the same period. This dual movement – more owed, less collected – represents a compounding form of revenue leakage that positive cash flow trends can obscure without dedicated monitoring of patient yield metrics.
CEOs should assess whether their revenue cycle management team has the bandwidth and visibility to track leakage by payer category, patient yield, and denial type simultaneously – because most teams managing daily operations are not resourced to reframe their tracking and reporting around net revenue impact. The vendor evaluation question is not whether to outsource, but whether current partners have the data capability and domain expertise to fill specific leakage intelligence gaps.
Cash flow improvements driven by operational efficiency – faster claim submission, shorter AR days, improved point-of-service collection – do not automatically translate to net revenue improvement if upstream leakage from denials and uncollected patient balances is growing faster. The 2025 data demonstrates this directly: hospitals improved cash cycle efficiency while net revenue leakage still grew 25%, meaning efficiency gains were being offset by structural revenue losses.
3Gen's revenue cycle management services are built around identifying and closing the leakage sources that cash flow metrics alone do not surface – including payer-specific denial pattern analysis, patient yield monitoring, and RCM workflow gaps that create ongoing net revenue loss. For healthcare organizations whose current vendor mix isn't providing this level of revenue intelligence, 3Gen offers both the expertise and the operational infrastructure to fill those gaps before they compound further.